Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	May 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2018
Stockholders Equity Note Disclosure [Line Items]
Aggregate intrinsic value of stock options exercised	$ 0.7	$ 2.4
Weighted average grant date fair value of share-based awards granted	$ 86.3	$ 76.64
Weighted average grant date fair value of restricted stock units granted	$ 176.86
Total unrecognized compensation cost	$ 73.2
Unrecognized compensation cost, weighted average remaining requisite service period	2 years 11 months 4 days
Number of unvested options and restricted stock units	2,154,003
Common stock, shares issued	55,744,896				55,557,698
Avitide LLC
Stockholders Equity Note Disclosure [Line Items]
Common stock, shares issued			42,621
Earnout consideration earned			50.00%
2018 Plan
Stockholders Equity Note Disclosure [Line Items]
Common stock shares reserved for Issuance						2,778,000
Incentive options, vesting period	1,717,510
Unvested Options
Stockholders Equity Note Disclosure [Line Items]
Incentive options, vesting period	5 years
Restricted Stock Units and Performance Stock Units
Stockholders Equity Note Disclosure [Line Items]
Aggregate intrinsic value of restricted stock units vested	$ 29.6	$ 37.5
Weighted average grant date fair value of restricted stock units granted	$ 176.86	$ 191.09
RestrictedStockUnitsRSUMember
Stockholders Equity Note Disclosure [Line Items]
Closing price of common stock				$ 141.46